In this episode I discuss bioequivalence testing and how it was developed to support generic drug approvals, but is now a mainstream tool for all of drug development. I discuss the basics of what bioequivalence means, how the studies are designed, and then how to perform the statistical analysis. I end with some examples of how this can be used for both generic drug and innovator drugs to support labeling.
Podden och tillhörande omslagsbild på den här sidan tillhör
Nathan Teuscher. Innehållet i podden är skapat av Nathan Teuscher och inte av,
eller tillsammans med, Poddtoppen.
